SRC and osteosarcoma: Our previous clinical studies have shown that Src/p-Src are potential biomarkers of osteosarcoma, which could promote the progression or metastasis of osteosarcoma and may lead to a poorer prognosis in clinical patients (Hu et al., 2015).